| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/16/2013 | CN102872219A Medicine composition with effects of clearing heat, purging fire, removing toxin, removing stasis, cooling blood, and stopping bleeding and preparation method thereof |
| 01/16/2013 | CN102872174A Method for preparing bupleurum injection |
| 01/16/2013 | CN102871995A Medicinal composition containing diclofenac sodium and preparation method thereof |
| 01/16/2013 | CN102423420B Traditional Chinese medicine combination for vision rehabilitation and preparation method thereof |
| 01/16/2013 | CN102416106B Chinese medicinal composition for treating middle-aged and senile eye disease and preparation method thereof |
| 01/16/2013 | CN101985464B High-stability PAC1 type receptor specific agonist MPAPO and preparation method and application thereof |
| 01/16/2013 | CN101945653B Compositions and methods for treating neurodegenerative diseases |
| 01/16/2013 | CN101730690B Sulfonamide compound, and crystal thereof |
| 01/16/2013 | CN101522669B Therapeutic lactams |
| 01/16/2013 | CN101411876B Neurotoxic oligomers |
| 01/16/2013 | CN101322683B Gel for eye containing bromfenac sodium hydrate and preparation thereof |
| 01/15/2013 | US8354448 Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes |
| 01/15/2013 | US8354409 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/15/2013 | CA2427774C Inhibitors of thromboxane formation and action |
| 01/10/2013 | WO2013005603A1 Agent for prevention and/or treatment of allergic inflammation in conjunctiva |
| 01/10/2013 | WO2013005037A1 Improvements in or relating to visual performance and/or macular pigmentation |
| 01/10/2013 | WO2013004766A1 Nk-1 receptor antagonists for treating corneal neovascularisation |
| 01/10/2013 | WO2013004551A1 Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors |
| 01/10/2013 | WO2012121988A3 Methods for treating diseases using isoindoline compounds |
| 01/10/2013 | WO2011151685A8 N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament |
| 01/10/2013 | US20130012893 Toroidal pharmaceutical formulations |
| 01/10/2013 | US20130012692 Sodium channel blockers |
| 01/10/2013 | US20130012573 Methods for intracellular delivery of nucleic acids |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012545 Amido-Thiophene Compounds and Their Use |
| 01/10/2013 | US20130012543 Cytoskeletal active rho kinase inhibitor compounds, composition and use |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
| 01/10/2013 | US20130012531 Treatment method |
| 01/10/2013 | US20130012529 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/10/2013 | US20130012517 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012515 Fused Bicyclic Pyridine and Pyrazine Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012514 Aminoalkyloxazole and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 01/10/2013 | US20130012505 Benzonaphthyridinamines as autotaxin inhibitors |
| 01/10/2013 | US20130012500 Organic compounds |
| 01/10/2013 | US20130012486 Combination steroid and glucocorticoid receptor antagonist therapy |
| 01/10/2013 | US20130012479 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012444 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130011486 Visual performance and/or macular pigmentation |
| 01/10/2013 | US20130011469 Krill oil and carotenoid composition, associated method and delivery system |
| 01/10/2013 | CA2840518A1 Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors |
| 01/10/2013 | CA2837047A1 Improvements in or relating to visual performance and/or macular pigmentation |
| 01/09/2013 | EP2542539A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 01/09/2013 | EP2542242A1 A3ar agonists for the treatment of uveitis |
| 01/09/2013 | EP2542233A1 Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
| 01/09/2013 | EP2542096A1 Nutraceutical chocolate or compound chocolate product |
| 01/09/2013 | CN102869345A Pharmaceutical composition for treatment of increased intraocular pressure |
| 01/09/2013 | CN102863901A Method for extracting coreopsis tinctoria oil resin by using supercritical or subcritical CO2 |
| 01/09/2013 | CN102863432A Modulators of cftr |
| 01/09/2013 | CN102861248A Bamboo charcoal eyeshade and preparation method thereof |
| 01/09/2013 | CN102861210A Drug combination for treating otitis media and preparation method thereof |
| 01/09/2013 | CN102861209A Composite aloe medicine liquid |
| 01/09/2013 | CN102861179A China aster composite capsule |
| 01/09/2013 | CN102861176A Eye-protection medicine bag |
| 01/09/2013 | CN102861174A Fumigating medicine for caring eyes |
| 01/09/2013 | CN102861173A Traditional Chinese medicine preparation method for treating myopia |
| 01/09/2013 | CN102861154A Traditional Chinese medicine for treating nerve deafness |
| 01/09/2013 | CN102860988A Chymotrypsin composition freeze-dried powder and preparation method thereof |
| 01/09/2013 | CN102860942A Nursing compound essential oil for eyes |
| 01/09/2013 | CN102188132B Myopia health care traditional Chinese medicinal pillow |
| 01/09/2013 | CN102040643B Ciclesonide nitrate derivative |
| 01/09/2013 | CN101935349B Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/09/2013 | CN101910160B Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 01/09/2013 | CN101759741B Compound and application thereof in preparation of medicine for treating angiogenesis |
| 01/08/2013 | US8349896 Aspirin-triggered lipid mediators |
| 01/08/2013 | CA2642668C Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/08/2013 | CA2571884C Hyaluronic acid in the enhancement of lens regeneration |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2485081C Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2423595C Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 01/03/2013 | WO2013003697A1 Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
| 01/03/2013 | WO2013003491A1 Toroidal pharmaceutical formulations |
| 01/03/2013 | WO2013003467A2 Methods for treating ocular inflammatory disorders |
| 01/03/2013 | WO2013003356A1 Compositions, uses, and preparation of platelet lysates |
| 01/03/2013 | WO2013003114A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | WO2013003113A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | WO2013002248A1 Phosphoric acid ester derivative |
| 01/03/2013 | WO2013001786A1 Eye fatigue suppression composition and food and drink containing same |
| 01/03/2013 | WO2013001080A1 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | WO2013000895A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | WO2013000406A1 Benzocycloheptanethiophene derivatives for anti-allergic reactions |
| 01/03/2013 | WO2012154627A3 Light delivery device and related compositions, methods and systems |
| 01/03/2013 | WO2012118863A9 Therapies that target autoimmunity for treating glaucoma and optic neuropathy |
| 01/03/2013 | US20130006182 Pharmaceutical compositions |
| 01/03/2013 | US20130005815 Aqueous intraocular penetration-promoting eye drop |
| 01/03/2013 | US20130005805 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | US20130005795 Use of Light Sensitive Genes |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005770 Organic compounds |
| 01/03/2013 | US20130005767 Therapeutic compounds |
| 01/03/2013 | US20130005753 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/03/2013 | US20130005752 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005751 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/03/2013 | US20130005750 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/03/2013 | US20130005741 Substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 01/03/2013 | US20130005732 New medical use of triazine derivatives |
| 01/03/2013 | US20130005730 Novel 1,3-oxazolidine compounds and their use as renin inhibitors |
| 01/03/2013 | US20130005729 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005728 Substituted pyrimidines as prostaglandin d2 receptor antagonists |